DK261289A - Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser - Google Patents

Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser Download PDF

Info

Publication number
DK261289A
DK261289A DK261289A DK261289A DK261289A DK 261289 A DK261289 A DK 261289A DK 261289 A DK261289 A DK 261289A DK 261289 A DK261289 A DK 261289A DK 261289 A DK261289 A DK 261289A
Authority
DK
Denmark
Prior art keywords
image
compounds
properties
condensed
diazepines
Prior art date
Application number
DK261289A
Other languages
Danish (da)
English (en)
Other versions
DK261289D0 (da
Inventor
Wolfhard Engel
Wolfgang Eberlein
Gerhard Mihm
Guenter Trummlitz
Norbert Mayer
Adriaan De Jonge
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of DK261289D0 publication Critical patent/DK261289D0/da
Publication of DK261289A publication Critical patent/DK261289A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/38—[b, e]- or [b, f]-condensed with six-membered rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromonomer-Based Addition Polymer (AREA)
  • Thermal Transfer Or Thermal Recording In General (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK261289A 1988-05-30 1989-05-29 Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser DK261289A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3818299A DE3818299A1 (de) 1988-05-30 1988-05-30 Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Publications (2)

Publication Number Publication Date
DK261289D0 DK261289D0 (da) 1989-05-29
DK261289A true DK261289A (da) 1989-12-01

Family

ID=6355412

Family Applications (1)

Application Number Title Priority Date Filing Date
DK261289A DK261289A (da) 1988-05-30 1989-05-29 Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser

Country Status (17)

Country Link
US (1) US5006522A (fi)
EP (1) EP0344543B1 (fi)
JP (1) JPH0228163A (fi)
KR (1) KR900018101A (fi)
AT (1) ATE78479T1 (fi)
AU (1) AU617814B2 (fi)
DD (1) DD283822A5 (fi)
DE (2) DE3818299A1 (fi)
DK (1) DK261289A (fi)
FI (1) FI892596A (fi)
HU (1) HU203887B (fi)
IL (1) IL90418A0 (fi)
NO (1) NO169539C (fi)
NZ (1) NZ229307A (fi)
PT (1) PT90677B (fi)
SU (1) SU1731057A3 (fi)
ZA (1) ZA894048B (fi)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3726908A1 (de) * 1987-08-13 1989-02-23 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0393604B1 (en) * 1989-04-20 1997-12-29 Boehringer Ingelheim Pharmaceuticals Inc. 6,11-Dihydro-5H-pyrido(2,3-b)(1,5,)benzodiazepin-5-ones and thiones and their use in the prevention or treatment of AIDS
DE3919076A1 (de) * 1989-06-10 1990-12-13 Thomae Gmbh Dr K Mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
WO1994022861A1 (en) * 1993-04-05 1994-10-13 Pharmaceutical Discovery Corporation PYRIDO[2,3-b][1,4]BENZODIAZEPINONES AS M2 RECEPTOR LIGAND FOR THE TREATMENT OF NEUROLOGICAL DISORDERS
US5561127A (en) * 1994-12-19 1996-10-01 Allelix Biopharmaceuticals, Inc. Muscarinic receptor ligands
JP3521569B2 (ja) * 1995-09-05 2004-04-19 ブラザー工業株式会社 印字制御装置
FR2850654A1 (fr) * 2003-02-03 2004-08-06 Servier Lab Nouveaux derives d'azepines tricycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
JP2010531854A (ja) * 2007-07-02 2010-09-30 エーシー イミューン ソシエテ アノニム 抗アミロイド剤としてのピレンゼピンおよびその誘導体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150125A (en) * 1959-09-22 1964-09-22 Wander Ag Dr A 5-(basic substituted)-10, 11-dihydro-11-oxo-5h-dibenzo[b, e][1, 4]diazepine compounds
US3105125A (en) * 1959-10-30 1963-09-24 Bell Telephone Labor Inc Power separation filter
ATE71097T1 (de) * 1985-06-27 1992-01-15 Thomae Gmbh Dr K In 11-stellung substituierte 5,11-dihydro-6hpyrido-(2,3-b>(1,4>benzodiazepin-6-one, verfahren zur ihrer herstellung und diese verbindungen enthaltende arzneimittel.
US4749788A (en) * 1987-04-13 1988-06-07 A. H. Robins Company, Incorporated Process for the preparation of aryl-pyrido(1,4) benzodiazepines
DE3819444A1 (de) * 1988-06-08 1989-12-14 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE3820346A1 (de) * 1988-06-15 1989-12-21 Thomae Gmbh Dr K Neue kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel

Also Published As

Publication number Publication date
NO892152L (no) 1989-12-01
NZ229307A (en) 1990-11-27
DK261289D0 (da) 1989-05-29
ZA894048B (en) 1991-02-27
DE3818299A1 (de) 1989-12-07
EP0344543B1 (de) 1992-07-22
HU203887B (en) 1991-10-28
FI892596A (fi) 1989-12-01
ATE78479T1 (de) 1992-08-15
EP0344543A2 (de) 1989-12-06
NO169539C (no) 1992-07-08
HUT50343A (en) 1990-01-29
PT90677B (pt) 1994-11-30
AU3585089A (en) 1989-11-30
IL90418A0 (en) 1990-01-18
KR900018101A (ko) 1990-12-20
NO169539B (no) 1992-03-30
DD283822A5 (de) 1990-10-24
EP0344543A3 (en) 1990-08-22
SU1731057A3 (ru) 1992-04-30
PT90677A (pt) 1989-11-30
US5006522A (en) 1991-04-09
FI892596A0 (fi) 1989-05-29
JPH0228163A (ja) 1990-01-30
AU617814B2 (en) 1991-12-05
DE58901872D1 (de) 1992-08-27
NO892152D0 (no) 1989-05-29

Similar Documents

Publication Publication Date Title
Leipsic Developmental (myelogenetic) localisation of the cerebral cortex in the human subject.
DK0812190T3 (da) R-enantiomer af N-propargyl-1-aminoindan til behandling af forskellige sygdomme og mesylat, esulat og sulfat deraf
DE69112895D1 (de) Pharmazeutische Verbindungen.
DK549189D0 (da) Galanthamin-analoge samt anvendelse af disse til fremstilling af laegemidler til behandling af alzheimer's syge
ATE168007T1 (de) Zur behandlung von erkrankungen des zentralnervensystems verwendbare benzimidazole
DE69012591T2 (de) Verwendung von Nikotin zur Herstellung eines Kit zur Behandlung von Krankheitszuständen, die auf eine Nikotinbehandlung ansprechen.
BE882833A (fr) Sels mixtes d'acides amines essentiels ou semi-essentiels et de leurs analogues exempts d'azote, en utilisant pour traiter des desordres renaux
TNSN88096A1 (fr) Nouveau n-(1-alkyl-3-hydroxy-4-piperidyl)
DK261289A (da) Kondenserede diazepiner, fremgangsmaader til fremstilling heraf og laegemidler indeholdende disse forbindelser
DE60108130D1 (de) Pharmazeutische zusammensetzungen zur behandlung von neurologischen krankheiten
NO921447D0 (no) Kondenserte diazepinoner, fremgangsmaate for deres fremstilling, og midler som inneholder disse forbindelser
DE69307702D1 (de) Verwendung von (e) - 2 - (p -fluorophenethyl)- 3 - fluoroallylamine zur behandlung der alzheimerschen krankheit
GR852035B (fi)

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment